August 13, 2024
As reported by Fiercehealthcare.com today in an article…
The genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. The company, through its Lemonaid Health business, plans to launch a GLP-1 weight loss telehealth membership by the end of the month, it announced last week along with its fiscal first-quarter financial results.
The service will enable members to be prescribed and receive brand-name or compounded semaglutide medications, the company said.
“The addition of weight loss management for our customers fits directly within our strategy of delivering services to improve an individual’s health through preventive actions. We also continue to add features to our membership services as we focus on creating longitudinal value that can help our members remain focused on improving their health,” Anne Wojcicki, co-founder and CEO of 23andMe, told investors during the earnings call Thursday.
In 2021, 23andMe spent $400 million to buy Lemonaid Health, a virtual care and pharmacy provider, to integrate its personalized genetics service more deeply into primary care.
Marketdata/DietBusinessWatch Commentary
One more company jumps on the GLP-1 bandwagon. What a surprise. The weight loss market is getting more and more crowded, making it more difficult for long-time players like Weight Watchers, Medifast and NutriSystem to compete, survive and grow. The pie is just too big to ignore. But, how good will the virtual care and support be? That’s the thing to watch.
Want More Analysis of The Weight Loss Market?
See Marketdata’s recent reports: “The U.S. Weight Loss Market: 2024 Status Report, and “The Telehealth Weight Loss Market”. Purchase online and Details and Tables of Contents found at: marketdataenterprises.com. Need deep analysis of competitors, historical market size and trends, past weight loss cycles, private company information, what MDs, hospitals and clinics are doing, dieter demographics? Marketdata has it. We perform custom research studies and consulting projects. Speak to the nation’s leading independent analyst of the weight loss market since 1989, with 50+ published reports – John LaRosa, MBA. Phone: 813-971-8080.